TFF PHARMACEUTICALS, INC. Debt Instrument, Convertible, Beneficial Conversion Feature
TFF PHARMACEUTICALS, INC. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $23.93 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-10.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2021-03-10
- TFF PHARMACEUTICALS, INC. debt instrument, convertible, beneficial conversion feature for fiscal 2020 was $23.93M, a 0.00% change from fiscal 2019.
- TFF PHARMACEUTICALS, INC. debt instrument, convertible, beneficial conversion feature for fiscal 2019 was $23.93M.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|
| 2020-12-31 | $23.93M 10-K · filed 2021-03-10 |
| 2019-12-31 | $23.93M 10-K · filed 2020-03-27 |